The polycystic ovary syndrome and the metabolic syndrome : a possible chronobiotic-cytoprotective adjuvant therapy

Mostrar todas las versiones(2)

Abstract: Polycystic ovary syndrome is a highly frequent reproductive-endocrine disorder affecting up to 8–10% of women worldwide at reproductive age. Although its etiology is not fully understood, evidence suggests that insulin resistance, with or without compensatory hyperinsulinemia, and hyperand...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Spinedi, Eduardo J., Cardinali, Daniel Pedro
Formato:	Artículo
Lenguaje:	Inglés
Publicado:	Hindawi 2019
Materias:	SINDROME METABOLICO MELATONINA INSULINA CRONOBIOLOGIA OVARIOS ANDRÓGENOS TEJIDO ADIPOSO
Acceso en línea:	https://repositorio.uca.edu.ar/handle/123456789/9089
Aporte de:	Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina

Ejemplares similares

The polycystic ovary syndrome and the metabolic syndrome: a possible chronobiotic-cytoprotective adjuvant therapy
por: Spinedi, Eduardo Julio, et al.
Publicado: (2018)

Cytoprotection by melatonin: The metabolic syndrome as an example
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
por: Cardinali, Daniel Pedro
Publicado: (2019)

Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: focus on Alzheimer's disease and melatonin
por: Spinedi, Eduardo J., et al.
Publicado: (2019)

Inflammaging, metabolic syndrome and melatonin : a call for treatment studies
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Polycystic ovary syndrome: physiopathology review
por: Fux Otta, Carolina, et al.
Publicado: (2013)

Melatonin, mitochondria, and the metabolic syndrome
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Differential expression and interaction of melatonin and thyroid hormone receptors with estrogen receptor α improve ovarian functions in letrozole-induced rat polycystic ovary syndrome
por: Ghosh, Hindole, et al.
Publicado: (2022)

Melatonin and the metabolic syndrome : physiopathologic and therapeutical implications
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Melatonin may curtail the metabolic syndrome : studies on initial and fully established fructose-induced metabolic syndrome in rats
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021)

Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021)

Melatonin as a chronobiotic/cytoprotective agent in bone: doses involved
por: Cardinali, Daniel Pedro
Publicado: (2024)

Rol de los andrógenos sobre la capacidad termogénica y la generación de adipocitos beige del tejido adiposo blanco
por: Harnichar, Alejandro Ezequiel
Publicado: (2022)

Melatonin and diet-induced metabolic syndrome in rats. Impact on the hypophysial-testicular axis
por: Scacchi Bernasconi, Pablo A., et al.
Publicado: (2019)

El sistema endocrino y el sueño
por: Cardinali, Daniel Pedro
Publicado: (2020)

Efficacy of melatonin in non-intensive care unit patients with COVID-19 pneumonia and sleep dysregulation
por: Brusco, Luis I., et al.
Publicado: (2022)

Melatonin as a prototype of chronobiotic-cytoprotective drugs
por: Cardinali, Daniel P.
Publicado: (2005)

Modificaciones del tejido adiposo asociadas al entrenamiento aeróbico y su implicancia en la transformación de la hipertrofia cardíaca patológica en un modelo de ratas espontáneamente hipertensas
por: Cavalli, Fiorella Anabel
Publicado: (2024)

Melatonin as a chronobiotic/cytoprotector : its role in healthy aging
por: Cardinali, Daniel Pedro
Publicado: (2020)

Neuroprotection in metabolic syndrome by environmental enrichment: a lifespan perspective
por: Kobiec, Tamara, et al.
Publicado: (2023)

Chronobiological theories of mood disorder
por: Zaki, Nevin F. W., et al.
Publicado: (2020)

Disrupted chronobiology of sleep and cytoprotection in obesity : possible therapeutic value of melatonin
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Ca2+ entry via TRPC1 is essential for cellular differentiation and modulates secretion via the SNARE complex
por: Schaar, Anne, et al.
Publicado: (2020)

Ca2+ entry via TRPC1 is essential for cellular differentiation and modulates secretion via the SNARE complex
por: Schaar, Anne, et al.
Publicado: (2020)

Coadministration of melatonin and insulin improves diabetes-induced impairment of rat kidney function
por: Hajam, Younis Ahmad, et al.
Publicado: (2022)

Metabolic syndrome in older adults: a poblational study
por: Díaz-Gerevini, GT, et al.
Publicado: (2023)

Impact of metabolic syndrome on murine fetal programming
por: Gerbaldo, V, et al.
Publicado: (2019)

The Metabolic syndrome and metabolic characteristics in blood donors
por: Aro, Pedro, et al.
Publicado: (2024)

Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood
por: Recabarren, S.E., et al.

Pituitary and testicular function in sons of women with polycystic ovary syndrome from infancy to adulthood
Publicado: (2008)

The use of chronobiotics in the resynchronization of the sleep/wake cycle : therapeutical application in the early phases of Alzheimer's disease
por: Cardinali, Daniel Pedro, et al.
Publicado: (2019)

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
por: Herrera, María I., et al.
Publicado: (2019)

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
por: Herrera, María Inés, et al.
Publicado: (2019)

Comparison of glycemic control in diabetic patients with and without metabolic syndrome
por: Cruz del Castillo, Aaron Humberto, et al.
Publicado: (2013)

Modulación de la respuesta a insulina en el ovario bovino y su relación con la enfermedad quística ovárica
por: Panzani, Carolina G., et al.
Publicado: (2015)

Elderly as a high‑risk group during COVID‑19 pandemic : effect of circadian misalignment, sleep dysregulation and melatonin administration
por: Cardinali, Daniel Pedro, et al.
Publicado: (2022)

Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high-fat fed rats
por: Ríos Lugo, María J., et al.
Publicado: (2019)

Metabolic syndrome prevalence and clinical features in blood donors
por: Cruz del Castillo, Aaron H., et al.
Publicado: (2012)

METABOLIC SYNDROME AND OBESITY ACCORDING TO IFD/LAAD CRITERIA IN ADULTS IN THE CITY OF SALTA
por: Gotthelf, Susana Judith, et al.
Publicado: (2018)